Keyphrases
Warfarin
78%
Warfarin Dose
46%
Atrial Fibrillation
41%
International Normalized Ratio
39%
Pharmacogenetics
36%
Warfarin Therapy
34%
Venous Thromboembolism
22%
Confidence Interval
22%
CYP2C9
18%
Bleeding
16%
VKORC1
15%
Multiple Myeloma
15%
Antithrombotic Therapy
14%
Genotype
14%
Risk Factors
13%
Anticoagulation
12%
Warfarin Initiation
12%
Cost-effectiveness
12%
Therapeutic Agents
11%
Aspirin
10%
Anticoagulant Therapy
10%
Anticoagulants
9%
High Risk
9%
Orthopaedic Patients
9%
High-sensitivity Cardiac Troponin
9%
Odds Ratio
8%
National Registry
8%
Stroke Prophylaxis
8%
Elderly Patients
8%
Coumarin
8%
Medicare Beneficiaries
8%
Non-valvular Atrial Fibrillation
7%
Clinical Outcomes
7%
Ischemic Stroke
7%
Stroke Risk
7%
Deep Vein Thrombosis
7%
Clinical Factors
7%
Thromboprophylaxis
7%
Hazard Ratio
6%
Major Bleeding
6%
Single nucleotide Polymorphism
6%
Heart Failure
6%
Anticoagulation Management Service
6%
Adjusted Hazard Ratio
6%
Periprocedural Myocardial Infarction
6%
Anemia
6%
Polymorphism
6%
Randomized Controlled Trial
5%
Chronic Atrial Fibrillation
5%
Hospitalization
5%
Pharmacology, Toxicology and Pharmaceutical Science
Warfarin
100%
Pharmacogenetics
35%
Atrial Fibrillation
30%
Venous Thromboembolism
22%
Bleeding
20%
Cerebrovascular Accident
19%
Anticoagulant Agent
17%
CYP2C9
12%
Multiple Myeloma
11%
Heart Infarction
7%
Congestive Heart Failure
7%
Acetylsalicylic Acid
7%
Brain Ischemia
6%
Thrombosis
6%
Adverse Event
6%
Antithrombotic Therapy
6%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
5%
Coumarin
5%
Medicine and Dentistry
Atrial Fibrillation
28%
Venous Thromboembolism
25%
Apoplexy
23%
Warfarin
19%
Bleeding
15%
Anticoagulation
10%
Cardiac Troponin
10%
Outpatient
9%
Multiple Myeloma
9%
Deep Vein Thrombosis
8%
Congestive Heart Failure
8%
Antithrombotic Therapy
8%
Myocardial Infarction
7%
Hip Arthroplasty
7%
Knee Arthroplasty
7%
Hazard Ratio
7%
Thrombosis
6%
Thromboprophylaxis
6%
Troponin T
6%
Medicare
5%
Odds Ratio
5%
Cardiovascular System
5%
Cost-Effectiveness Analysis
5%
Left Ventricular Assist Device
5%
Antithrombotic
5%
Anticoagulant
5%
Malignant Neoplasm
5%